Furthermore, LRP5 regulates the lung microvasculature via angiopoietin-Tie 2 pathway modulation, indicating that LRP5 is a potentially effective therapeutic target in pulmonary hypertension [42]. The gene discussed is LRP5; the disease is pulmonary arterial hypertension.